Skip to main content

Table 1 Baseline characteristics of the included patients

From: High flow nasal cannula oxygen and non-invasive mechanical ventilation in management of COVID-19 patients with acute respiratory failure: a retrospective observational study

 

All patients (n=63)

HFNCO (n=37)

NIV (n=26)

P#

Age (years)

66.44 ± 8.86

67.94 ± 7.82

64.10 ± 9.81

0.065

Gender

 Males (%)

40 (63.34%)

23 (62.16%)

17 (65.38%)

 

 Females (%)

23 (36.50%)

14 (37.83%)

9 (34.61%)

 

Comorbidities

 Diabetes Mellitus

21 (33.33%)

12 (32.43%)

9 (34.61%)

 

 Hypertension

19 (30.15%)

10 (27.02%)

9 (34.61%)

 

 Chronic cardiac disease

3 (4.76%)

2 (5.40%)

1 (3.84%)

 

 Chronic respiratory disease

6 (9.52%)

3 (8.10%)

3 (11.53%)

 

 Others

1 (1.58%)

1 (2.70%)

-

 

APACHE II score

10.26 ± 3.22

9.78 ± 3.18

10.96 ± 3.15

0.07

SOFA score

2.88 ± 0.89

3.02 ± 0.94

2.69 ± 0.77

0.07

  1. HFNCO high flow nasal cannula oxygen, NIV non-invasive ventilation, APACHE Acute Physiology and Chronic Health Evaluation, SOFA sequential organ failure assessment
  2. #P for comparison between HFNCO and NIV, significance at P<0.05